Ingredient
4-Chlororesorcinol
4-Chlororesorcinol is flagged for pregnancy and trying to conceive. The concern behind the strongest flag is absorbed into the body.
- 4-Chloro-1,3-benzenediol
- p-Chlororesorcinol
Verdict by profile
Truva checks every ingredient against six profiles. Jump to any of them for the full assessment.
- Strongest verdict
- Caution Advised
- Its verdict for pregnancy, the profile this one is worst in
- Profiles flagged
- 2 of 6
- Counting avoid, high risk and medium risk
- Irritancy
- 2 of 5
- Higher means more likely to sting or redden
4-Chlororesorcinol and pregnancy
Caution Advised
- Absorbed into the body
4-Chlororesorcinol is a chlorinated phenolic compound used in hair dyes and skin-lightening products to inhibit melanin production. It works by interfering with the enzyme tyrosinase, which is essential for pigment formation. There are no specific pregnancy studies on topical 4-chlororesorcinol, creating uncertainty about its safety during pregnancy. While the EU restricts its concentration to 0.5% in cosmetics, systemic absorption of phenolic compounds through the skin is possible. Given its chemical structure and ability to interfere with enzymatic processes, many dermatologists recommend avoiding unnecessary exposure to skin-lightening agents during pregnancy as a precautionary measure. The SCCS has reviewed this ingredient for cosmetic safety but has not issued specific pregnancy guidance. Most obstetricians advise pregnant women to avoid non-essential skin treatments, particularly those that alter melanin production, as hormonal changes during pregnancy already affect pigmentation naturally.
4-Chlororesorcinol and breastfeeding
Safe to Use
4-Chlororesorcinol is used in hair dyes and skin-lightening products, typically in restricted concentrations. When applied topically, systemic absorption is generally minimal, especially when used according to product directions. While specific studies on breastfeeding are not available, the topical application of 4-chlororesorcinol at regulated concentrations (0.5% or less) is unlikely to result in significant systemic levels that would transfer to breast milk. The compound is primarily metabolized in the skin and liver. Most dermatologists consider regulated cosmetic use of this ingredient acceptable during breastfeeding, though avoiding application near the breast area is recommended. The AAD notes that most topical cosmetic ingredients used as directed pose minimal risk during breastfeeding. If skin irritation or allergic reactions occur, discontinue use and consult a healthcare provider.
4-Chlororesorcinol and postpartum
Safe to Use
- Irritant
For postpartum women not breastfeeding, 4-chlororesorcinol can be beneficial in addressing pregnancy-related hyperpigmentation such as melasma, which commonly persists after delivery. It works by inhibiting tyrosinase, the enzyme responsible for melanin production. At regulated concentrations (0.5% or less), this ingredient is generally well-tolerated, though some individuals may experience mild skin irritation. Starting with products containing lower concentrations and performing a patch test can help minimize irritation risk. The SCCS has deemed it safe for cosmetic use within established concentration limits.
4-Chlororesorcinol and trying to conceive
Caution Advised
- Absorbed into the body
4-Chlororesorcinol is a melanin synthesis inhibitor used in hair dyes and skin-lightening products. When trying to conceive, the same precautions that apply to early pregnancy are generally recommended, as you may be pregnant before knowing it. While there are no specific studies showing harm to fertility or early embryonic development, the lack of pregnancy-specific safety data means most healthcare providers suggest avoiding non-essential skin-lightening treatments when actively trying to conceive. This conservative approach ensures no potential risk during the critical early weeks of conception and implantation.
4-Chlororesorcinol and PCOS
Safe to Use
4-Chlororesorcinol is a tyrosinase inhibitor used for skin brightening and treating hyperpigmentation. It has no known hormonal activity or effects on androgen or insulin pathways relevant to PCOS. Women with PCOS often experience hyperpigmentation, acanthosis nigricans, or post-inflammatory marks from acne. This ingredient can help address these pigmentation concerns when used in regulated concentrations. The SCCS considers it safe for cosmetic use at concentrations up to 0.5%. There are no specific concerns for women with PCOS using products containing 4-chlororesorcinol. Standard precautions include patch testing to check for sensitivity and using sunscreen, as skin-lightening treatments can increase photosensitivity.
4-Chlororesorcinol and general use
Safe to Use
- Irritant
- Common allergen
4-Chlororesorcinol is a synthetic tyrosinase inhibitor used in hair dyes and skin-lightening products. It works by blocking the enzyme responsible for melanin production, making it effective for treating hyperpigmentation, age spots, and uneven skin tone. The primary concerns with this ingredient are mild skin irritation and potential allergic contact dermatitis in sensitive individuals. The EU Scientific Committee on Consumer Safety has reviewed its safety profile and established concentration limits to minimize these risks. Patch testing before full application is recommended. The EU Cosmetics Regulation permits 4-chlororesorcinol at concentrations up to 0.5% with appropriate labeling. It has a moderate safety profile when used as directed. Users should apply sunscreen during the day, as lightening agents can increase sun sensitivity.
Everything else flagged for the same profiles
Related ingredients
Ingredients suggested in place of 4-Chlororesorcinol, each one with its own page here.
Ingredients that raise the same concerns.
Where this came from
Truva summarises published guidance from bodies including ACOG, the FDA, the EU SCCS and the Cosmetic Ingredient Review. It has no access to your medical history and it is not a substitute for your doctor, dermatologist or midwife. These assessments have not been reviewed by a clinician, and nothing here is a diagnosis or a prescription. If you are pregnant, breastfeeding or being treated for PCOS, take the ingredient list to the person looking after you.
Assessment last pulled from the ingredient database on .
One ingredient is the easy case.
A label has thirty of them. Truva reads the whole list at once and answers for the profile you set: pregnancy, breastfeeding, postpartum, trying to conceive, PCOS, or general use.
Download on theApp Store